The National Medical Research Centre for Hematology is a medical research institute in Moscow funded by the Ministry of Health of the Russian Federation.

During the past decade, National Research Center for Hematology conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Research Center for Hematology" #1 collaborator was "Botkin Hospital" with 1 trials as a collaborator, "Clinical hospital №1 of Sverdlovsk region" with 1 trials as a collaborator, "DNKOM LLC" with 1 trials as a collaborator, "Enrollme.ru, LLC" with 1 trials as a collaborator and "Federal Research Clinical Center of Federal Medical & Biological Agency, Russia" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "National Research Center for Hematology" are "Warm Antibody Autoimmune Hemolytic Anemia" (2 trials), "AML" (1 trials), "Acute Myeloid Leukemia" (1 trials), "BCR-ABL Positive Chronic Myelogenous Leukemia" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "National Research Center for Hematology" in a lesser frequency.

Most popular intervention types in "National Research Center for Hematology" are "Drug" (9 trials), "Procedure" (2 trials), "Diagnostic Test" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fostamatinib disodium" (2 trials), "R-DA-EPOCH-21" (2 trials), "R-DA-EPOCH-21 + auto-SCT" (2 trials), "Autologous HSCT" (1 trials) and "Bosutinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Research Center for Hematology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "National Research Center for Hematology". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in National Research Center for Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Research Center for Hematology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".